We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
1-Year Est. Return
41.24%
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$67.5B
AUM Growth
+$10.9B
(+19%)
Cap. Flow
+$12.7B
Cap. Flow
% of AUM
18.75%
Top 10 Holdings %
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195
Avg Time Held
26.2
quarters
Top 10 Avg Time Held
23.4
quarters
Top 20 Avg Time Held
21.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$19.7B |
| 2 |
Walmart Inc
WMT
|
+$729M |
| 3 |
Kimberly-Clark
KMB
|
+$33.1M |
| 4 |
Erie Indemnity
ERIE
|
+$26.7M |
| 5 |
Becton Dickinson
BDX
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$799M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
Microsoft
MSFT
|
+$445M |
| 4 |
Amazon
AMZN
|
+$321M |
| 5 |
Broadcom
AVGO
|
+$274M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.2% |
| 2 | Technology | 23.92% |
| 3 | Consumer Staples | 7.59% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Communication Services | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Strata Critical Medical Inc
SRTA
$380M
| $42K | ﹤0.01% |
10,040
-2,439
| -20% | -$11.7K |
2024 Q3
6 quarters
|
|
1802
DELISTED
Olaplex Holdings
OLPX
| $41.3K | ﹤0.01% |
20,367
-5,391
| -21% | -$8.27K |
2024 Q3
6 quarters
|
|
1803
The Honest Company
HNST
$549M
| $40.4K | ﹤0.01% |
13,729
-3,334
| -20% | -$8.58K |
2024 Q3
6 quarters
|
|
1804
Alight
ALIT
$243M
| $39.3K | ﹤0.01% |
3,368
-574
| -15% | -$13.7K |
2022 Q2
15 quarters
|
|
1805
Standard BioTools
LAB
$257M
| $38.3K | ﹤0.01% |
41,674
-13,034
| -24% | -$15.8K |
2024 Q3
6 quarters
|
|
1806
Acco Brands
ACCO
$418M
| $38K | ﹤0.01% |
12,670
-3,302
| -21% | -$12.4K |
2020 Q2
23 quarters
|
|
1807
Krispy Kreme
DNUT
$533M
| $37.9K | ﹤0.01% |
11,184
-2,852
| -20% | -$9.84K |
2023 Q2
11 quarters
|
|
1808
Evolent Health
EVH
$529M
| $36.9K | ﹤0.01% |
16,174
-5,275
| -25% | -$16.7K |
2020 Q4
21 quarters
|
|
1809
Coherus Oncology
CHRS
$164M
| $36.7K | ﹤0.01% |
21,700
-3,018
| -12% | -$5.36K |
2015 Q4
41 quarters
|
|
1810
Starling Oncology
STLN
$672M
| $35.5K | ﹤0.01% |
11,561
-908
| -7% | -$2.78K |
2025 Q2
3 quarters
|
|
1811
OmniAb
OABI
$688M
| $35.4K | ﹤0.01% |
22,552
-3,024
| -12% | -$5.46K |
2023 Q2
11 quarters
|
|
1812
Eve Holding
EVEX
$519M
| $34.5K | ﹤0.01% |
13,898
-3,624
| -21% | -$12.4K |
2025 Q4
1 quarter
|
|
1813
Ready Capital
RC
$177M
| $34.4K | ﹤0.01% |
21,230
-5,894
| -22% | -$11.3K |
2021 Q4
17 quarters
|
|
1814
Holley
HLLY
$303M
| $34K | ﹤0.01% |
11,076
-2,885
| -21% | -$10.9K |
2024 Q4
5 quarters
|
|
1815
Bumble
BMBL
$783M
| $34K | ﹤0.01% |
10,426
-2,878
| -22% | -$9.57K |
2022 Q2
15 quarters
|
|
1816
Eledon Pharmaceuticals
ELDN
$188M
| $33.4K | ﹤0.01% |
10,832
+566
| +6% | +$1.33K |
2025 Q4
1 quarter
|
|
1817
8x8 Inc
EGHT
$296M
| $33K | ﹤0.01% |
19,903
-4,544
| -19% | -$9.3K |
2020 Q2
23 quarters
|
|
1818
EVgo
EVGO
$153M
| $32.4K | ﹤0.01% |
18,815
-4,615
| -20% | -$12.3K |
2023 Q3
10 quarters
|
|
1819
Microvision
MVIS
$36.1M
| $32.3K | ﹤0.01% |
3,358
-726
| -18% | -$8.31K |
2021 Q2
19 quarters
|
|
1820
Rezolute
RZLT
$436M
| $32K | ﹤0.01% |
10,494
-4,263
| -29% | -$12.8K |
2025 Q2
3 quarters
|
|
1821
Claros Mortgage Trust
CMTG
$171M
| $31.9K | ﹤0.01% |
13,383
-3,485
| -21% | -$9.03K |
2022 Q2
15 quarters
|
|
1822
Hyliion Holdings
HYLN
$607M
| $31.6K | ﹤0.01% |
17,971
-4,681
| -21% | -$9.42K |
2021 Q2
19 quarters
|
|
1823
Outdoor Holding Co
POWW
$263M
| $30.9K | ﹤0.01% |
15,351
-496
| -3% | -$944 |
2022 Q4
13 quarters
|
|
|
SVC
1824
Service Properties Trust
SVC
$778M
| $30.8K | ﹤0.01% |
4,549
-1,101
| -19% | -$11.5K |
2013 Q2
51 quarters
|
|
1825
OraSure Technologies
OSUR
$259M
| $30.3K | ﹤0.01% |
10,090
-2,876
| -22% | -$8.19K |
2024 Q3
6 quarters
|
|
Similar funds
ProShare Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 0.01% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.
- ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
- ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
- ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
- ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
- ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
- ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.